Cargando…

Cost-Effectiveness of COVID-19 Sequential Vaccination Strategies in Inactivated Vaccinated Individuals in China

To effectively prevent and control the COVID-19 pandemic, countries have adopted a booster vaccination strategy. This study aimed to estimate the cost-effectiveness of sequential booster COVID-19 vaccination compared to two-dose inactivated vaccination in China from a societal perspective. A Markov...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Yaqun, Zhao, Jingyu, Wei, Xia, Han, Peien, Yang, Li, Ren, Tao, Zhan, Siyan, Li, Liming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610874/ https://www.ncbi.nlm.nih.gov/pubmed/36298577 http://dx.doi.org/10.3390/vaccines10101712

Ejemplares similares

Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies
por: Fu, Yaqun, et al.
Publicado: (2022)

EE19 Cost-Effectiveness Analysis of Nonpharmaceutical Interventions Combined with Inactivated Vaccination and Oral Medicine in China
por: Fu, F., et al.
Publicado: (2023)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
por: Dong, Wei, et al.
Publicado: (2018)

Progress of Active Surveillance for Vaccine Safety in China
por: Liu, Zhike, et al.
Publicado: (2021)

Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in China
por: Hu, Yuemei, et al.
Publicado: (2019)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis — Beijing, China, 2014–2016
por: Zhao, Dan, et al.
Publicado: (2017)

EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis
por: Fu, Y., et al.
Publicado: (2023)

Cost-effectiveness of various immunization schedules with inactivated Sabin strain polio vaccine in Hangzhou, China
por: Xu, Yuyang, et al.
Publicado: (2022)

Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine
por: Peng, Pai, et al.
Publicado: (2021)

Immune Protective Efficacy of China’s Traditional Inactivated and Attenuated Vaccines against the Prevalent Strains of Pasteurella multocida in Mice
por: Guan, Li-Jun, et al.
Publicado: (2021)

Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
por: Fan, Shengtao, et al.
Publicado: (2021)

Assessing Spatial Accessibility to Primary Health Care Services in Beijing, China
por: Zhang, Jiawei, et al.
Publicado: (2021)

Polio inactivated vaccine costs into routine childhood immunization in Brazil
por: Sartori, Ana Marli Christovam, et al.
Publicado: (2015)

Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine
por: Mvundura, Mercy, et al.
Publicado: (2019)

Evaluation of PastoCovac plus vaccine as a booster dose on vaccinated individuals with inactivated COVID-19 vaccine
por: Farahmand, Behrokh, et al.
Publicado: (2023)

Febrile Seizures and Measles-Containing Vaccines in China: A Self-Controlled Case Series Study
por: Xu, Lu, et al.
Publicado: (2021)

Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China
por: Zhang, Hangjie, et al.
Publicado: (2023)

Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey
por: Xu, Jiawei, et al.
Publicado: (2021)

High-dose inactivated influenza vaccine is associated with cost savings and better outcomes compared to standard-dose inactivated influenza vaccine in Canadian seniors
por: Becker, Debbie L., et al.
Publicado: (2016)

Vaccination coverage estimates and utilization patterns of inactivated enterovirus 71 vaccine post vaccine introduction in Ningbo, China
por: Ye, Lixia, et al.
Publicado: (2021)

Screening immune adjuvants for an inactivated vaccine against Erysipelothrix rhusiopathiae
por: Guan, Li-Jun, et al.
Publicado: (2022)

Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany
por: Kuchenbecker, Ulrike, et al.
Publicado: (2018)

Inactivation of Viruses for Vaccines
por: Pollard, Ernest
Publicado: (1957)

Inactivated Viral Vaccines
por: Sanders, Barbara, et al.
Publicado: (2014)

Safety, immunogenicity, and immune persistence of two inactivated COVID-19 vaccines replacement vaccination in China: An observational cohort study
por: Wang, Xiaoqi, et al.
Publicado: (2022)

Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS‐CoV‐2 vaccine
por: Xu, Xingli, et al.
Publicado: (2022)

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
por: Liu, Xiaoqiang, et al.
Publicado: (2022)

Current and next-generation formulation strategies for inactivated polio vaccines to lower costs, increase coverage, and facilitate polio eradication
por: Kumar, Prashant, et al.
Publicado: (2022)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Vaccine pricing strategies in China
por: Zhang, Haonan, et al.
Publicado: (2023)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
por: Li, Juan, et al.
Publicado: (2021)

Glycerol Monolaurate to Ameliorate Efficacy of Inactivated Pseudorabies Vaccine
por: Ren, Qinghai, et al.
Publicado: (2022)

Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight
por: Zhu, Qian, et al.
Publicado: (2022)

Psychological profiles of COVID vaccine-hesitant individuals and implications for vaccine message design strategies
por: Zhou, Yanmengqian, et al.
Publicado: (2023)

Safety and Immunogenicity of the Inactivated COVID-19 Vaccine Booster in People Living with HIV in China
por: Yi, Yunyun, et al.
Publicado: (2023)

Transcriptome Analysis of Peripheral Blood Mononuclear Cells in SARS-CoV-2 Naïve and Recovered Individuals Vaccinated With Inactivated Vaccine
por: Zhang, Yuwei, et al.
Publicado: (2022)

Inactivated canine coronavirus vaccine
Publicado: (1986)

Immunogenicity and safety of an inactivated enterovirus 71 vaccine coadministered with trivalent split-virion inactivated influenza vaccine: A phase 4, multicenter, randomized, controlled trial in China
por: Chen, Yaping, et al.
Publicado: (2022)

Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection
por: Fu, Yu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3hghqt42p1u8fhap6aqp3308sb